Maybe take a look at the November 2021 posts if you want to see ramping. I am not ramping. Simply pointing out as others have said more expansively, that a capital raise (or funds from some other source) was clearly necessary to proceed with business as planned. The company is forecasting yearly revenues of US$270 million and EBITDA of US$40 million off of 3,600 NdFeB alloy tpa and 1,600 CuTi alloy tpa for 2024.
First and foremost it needs to cover costs to be even able to begin to produce a sixth of those amounts i.e. the 600tpa of NdFeB alloy it is planning for 1H23CY. Once the cash flows start and get put back in as production capital, this could be a spring board for the company's ambitions proper.
I feel sorry for long-term shareholders who did not sell on the silly prices of late 2021 - but not too sorry, as I sold out far too early in 2021. Again, I am buying ALK and ASM at better levels than I sold post-demerger and both businesses net are arguably better than they were in July 2020.
ASM Price at posting:
$1.98 Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)